Explore the role of genetics in kidney disease with 6 concise 15-min modules. Learn about genetic testing, clinical applications, and barriers to access.

Esophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care - Module 2

Available until 8/6/2026
0.5 CME credits available (0.5 pharmacology)
Posted by i3 Health on 10/28/2025

Free CME/AAPA: Module 2 dives into new trial results, key biomarkers, and evolving strategies in esophagogastric cancer. Sharpen PA decision-making to deliver up-to-date, personalized care.

Podcast - Esophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care - Module 2

Available until 8/6/2026
0.5 CME credits available (0.5 pharmacology)
Posted by i3 Health on 10/28/2025

FREE CME/AAPA: Practical tips when to test, how to personalize, and how to sequence and manage toxicity across esophageal, gastric, and GEJ.

Esophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care - Module 1

Available until 8/6/2026
0.5 CME credits available (0.5 pharmacology)
Posted by i3 Health on 10/28/2025

Free CME/AAPA: Get up to speed on esophagogastric cancer including: key biomarkers (HER2, PD-L1, MSI-H/MMR, CLDN18.2, FGFR2), testing methods, and how to pick targeted and immunotherapies.

Podcast - Esophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care - Module 1

Available until 8/6/2026
0.5 CME credits available (0.5 pharmacology)
Posted by i3 Health on 10/28/2025

FREE CME/AAPA: The latest on HER2, PD-L1, MSI-H/MMR, CLDN18.2, FGFR2, and evolving targeted/immunotherapies.

Esophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care - Module 3

Available until 8/6/2026
0.5 CME credits available (0.5 pharmacology)
Posted by i3 Health on 10/28/2025

FREE CME/AAPPA - Practice real-world decisions, apply molecular profiling, and hone team-based care to improve outcomes. Module 3 is a gamified, case-based deep dive into esoph. cancers.

Increasing Detection and Improving Outcomes in Hereditary Transthyretin Amyloid Cardiomyopathy

Available until 8/12/2026
1.0 CME credit available (0.5 pharmacology)
Posted by i3 Health on 10/28/2025

FREE CME/AAPA:ATTR-CM often hides in plain sight! Sharpen your diagnostic skills with genetic testing and learn optimal therapies to improve patient outcomes. Don't miss this accredited activity!

Optimizing Neuroendocrine Tumor Outcomes: Closing the Gaps in Diagnosis and Care

Available until 8/18/2026
1.25 CME credits available
Posted by i3 Health on 10/28/2025

FREE CME/AAPA: ATTR-CM often hides in plain sight. Join Dr. Maurer to spot it sooner with genetic testing, refine diagnosis, and choose optimal therapies to improve outcomes.

Podcast: Clinical Challenges in Extrapulmonary NEC: Expert Insights on Diagnosis, Treatment, and Emerging Targets

Available until 9/8/2026
0.75 CME credits available
Posted by i3 Health on 10/28/2025

FREE CME/AAPA: Rare, fast-moving EP-NECs demand savvy care. Hear the latest on targeted agents, checkpoint inhibitors, and radionuclide therapy—plus team-based tactics to boost outcomes.

Clinical Challenges in Extrapulmonary NEC: Expert Insights on Diagnosis, Treatment, and Emerging Targets

Available until 9/8/2026
0.75 CME credits available
Posted by i3 Health on 10/28/2025

FREE CME/AAPA: Rare, fast-moving EP-NECs demand savvy care. Hear the latest on targeted agents, checkpoint inhibitors, and radionuclide therapy—plus team-based tactics to boost outcomes.